Polyamine metabolism is associated with the oncogene MYC, which drives cells to increase the expression and activity of ODC, promoting the proliferation of cancers related to dysregulated polyamine metabolism [40,41] (including leukemia [42,43], lung cancer [44], neuroblastoma [44,45,46], and breast cancer [47]). Here, MYC is linked to breast carcinoma.